Regenxbio (RGNX) Accumulated Expenses (2014 - 2026)
Regenxbio's Accumulated Expenses came in at $23.07 million for Q2 2026, down 35.1% from $35.56 million a year earlier.
Powered by 
Analysis
Regenxbio (RGNX) Accumulated Expenses (2014 - 2026) Analysis & Trends
At the end of FY2025, Regenxbio's Accumulated Expenses was $38.39 million, up 0.8% from FY2024.
- Accumulated Expenses carries a five-year compound annual growth rate of -4.8% (FY2020 to FY2025).
- Going back by year, Accumulated Expenses was $38.07 million in FY2024 (-23.4%), $49.7 million in FY2023 (+6.2%), $46.79 million in FY2022 (-38.5%) and $76.11 million in FY2021 (+55.1%).
- The Q2 2026 figure represents the lowest quarterly Accumulated Expenses since Q1 2020.
- Year-over-year, Accumulated Expenses increased in two of the last seven quarters, with an average decline of 16.8%.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q4 2021 (growth of 55.1%), and the weakest in Q4 2022 (a decline of 38.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Regenxbio | 407.85 Mn | -525.24 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.07 Mn |
| Dec 31, 2025 | 38.39 Mn |
| Sep 30, 2025 | 38.32 Mn |
| Jun 30, 2025 | 35.56 Mn |
| Mar 31, 2025 | 23.60 Mn |
| Dec 31, 2024 | 38.07 Mn |
| Sep 30, 2024 | 48.64 Mn |
| Jun 30, 2024 | 42.49 Mn |
| Mar 31, 2024 | 33.13 Mn |
| Dec 31, 2023 | 49.70 Mn |
| Sep 30, 2023 | 45.66 Mn |
| Jun 30, 2023 | 50.52 Mn |
| Mar 31, 2023 | 31.71 Mn |
| Dec 31, 2022 | 46.79 Mn |
| Sep 30, 2022 | 44.46 Mn |
| Jun 30, 2022 | 47.01 Mn |
| Mar 31, 2022 | 48.42 Mn |
| Dec 31, 2021 | 76.11 Mn |
| Sep 30, 2021 | 49.69 Mn |
| Jun 30, 2021 | 46.76 Mn |
API Access
Regenxbio Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();